VF
INO icon

Virtu Financial’s Inovio Pharmaceuticals INO Stock Holding History

Virtu Financial’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,040
Closed -$77K – 1957
2025
Q4 		$77K Buy
+44,040
New +$97K ﹤0.01% 1245
2025
Q3 		– Sell
-38,482
Closed -$78K – 1760
2025
Q2 		$78K Buy
+38,482
New +$73.7K ﹤0.01% 1067
2023
Q3 		– Sell
-3,992
Closed -$21K – 1573
2023
Q2 		$21K Buy
+3,992
New +$32.2K ﹤0.01% 1251
2023
Q1 		– Sell
-4,984
Closed -$93K – 1773
2022
Q4 		$93K Sell
4,984
-5,918
-54% -$134K 0.01% 980
2022
Q3 		$226K Buy
10,902
+3,777
+53% +$96.7K 0.02% 802
2022
Q2 		$148K Buy
+7,125
New +$201K 0.01% 850
2021
Q4 		– Sell
-2,528
Closed -$217K – 1929
2021
Q3 		$217K Buy
+2,528
New +$254K 0.02% 881
2021
Q2 		– Sell
-959
Closed -$107K – 1767
2021
Q1 		$107K Sell
959
-6,042
-86% -$795K 0.01% 1300
2020
Q4 		$744K Buy
7,001
+1,360
+24% +$181K 0.08% 314
2020
Q3 		$785K Buy
+5,641
New +$1.18M 0.13% 170
2019
Q4 		$88K Buy
2,212
+948
+75% +$28.5K 0.01% 1106
2019
Q3 		$31K Sell
1,264
-724
-36% -$22K ﹤0.01% 1249
2019
Q2 		$70K Buy
+1,988
New +$79K ﹤0.01% 1188
2019
Q1 		– Sell
-2,610
Closed -$125K – 1619
2018
Q4 		$125K Buy
+2,610
New +$159K 0.01% 1074
2018
Q2 		– Sell
-3,469
Closed -$196K – 2231
2018
Q1 		$196K Buy
3,469
+1,303
+60% +$70.5K 0.01% 1370
2017
Q4 		$107K Sell
2,166
-1,818
-46% -$113K 0.01% 1899
2017
Q3 		$303K Buy
+3,984
New +$296K 0.02% 1373

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's INO Position: Q1 2026 in Review

Virtu Financial sold out of Inovio Pharmaceuticals (INO) in Q1 2026, closing a stake of 44,040 shares — an estimated $77K sold.

Virtu Financial first reported a position in INO in Q3 2017 and held it in 17 quarters. The position peaked at $785K in Q3 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Virtu Financial reported no remaining Inovio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 44,040 Inovio Pharmaceuticals shares in Q1 2026, an estimated $77K.
  • Virtu Financial first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 17 quarters.
  • Virtu Financial's Inovio Pharmaceuticals position peaked at $785K in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.